Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: fosphenytoin / codeine / morphine attending: chief complaint: metastatic breast cancer major surgical or invasive procedure: left temporal craniotomy history of present illness: 58-year-old female with a history of metastatic breast carcinoma with metastases to the brain. the patient had previously undergone radiotherapy in with stereotactic radiosurgery performed in . the patient presented most recently to brain tumor clinic in followup on to dr. . the patient complained at this time about new balance problems. she was followed up routinely with an mri scan on and remains on an hki-272 protocol for treatment. at the time of her brain tumor clinic visit, it was noted on the mri that her left temporal lesion had increased in size. past medical history: oncology history: somewhat unclear as patient longtime patient of and no recent synopsis of treatments: -patient with breast cancer with stable mets to brain, ribs -initially diagnosed with right breast cancer in . biopsy at that time revealed an infiltrating ductal carcinoma and the patient underwent a mastectomy (tumor size was 4.5 cm, er positive, and her2neu positive). -approximately 14 months after mastectomy, underwent six cycles of cmf therapy. -: left hip met -initiated care w/ dr. in ; xrt and herceptin -navelbine and herceptin -herceptin and carboplatin -now with brain and rib mets -has been on multiple protocols -currently on hk1-272 04-266 trial with several recent dose reductions, zometa last received on -seen in ed on with rib pain, ruled out for pe, thought to be due to known metastases. other pmh: asthma and elevated cholesterol. social history: she lives w/ her husband, and she has 4 grown children. she is a lifetime non- smoker and rare alcohol use. family history: non-contributory. physical exam: awake, alert, oriented x3 afebrile with vital signs stable perrl, eomi bilaterally rrr, ctab full motor strength in all extremities full sensory exam throughout pertinent results: 02:33pm pt-12.1 ptt-52.0* inr(pt)-1.0 02:33pm plt count-223 03:40pm glucose-79 lactate-0.9 na+-132* k+-3.1* cl--100 04:33pm glucose-102 lactate-0.8 na+-135 k+-3.1* cl--100 06:30pm pt-12.0 ptt-24.7 inr(pt)-1.0 06:30pm plt count-232 06:30pm calcium-8.5 phosphate-3.2 magnesium-1.9 brief hospital course: the patient presented to the hospital for surgery on . she underwent a left temporal craniotomy for removal of her mass. the surgery went as planned with no complications and minimal blood loss. she then stayed in the pacu overnight as standard for craniotomy patients. she had regular hourly neurologic and vital signs checks. she was started on decadron, gi prophylaxis, a bowel regimen, and sliding scale insulin. she had an uncomplicated pacu course and was transferred to the regular floor on . she continued to do well on the floor. her vital signs and lab results remained normal as her decadron dose was tapered and her activity was increased. her foley catheter was discontinued after she was moved to the regular floor. she continued to improve and was discharged on . medications on admission: advair, aranesp, coumadin, flonase, , lamictal, lipitor, lorazepam, magnesium sulfate, nexium, singulair, zyrtec, hkl-272 (trial drug) discharge medications: 1. insulin regular human 100 unit/ml solution sig: one (1) unit injection asdir (as directed): see sliding scale. disp:*100 units* refills:*2* 2. lamotrigine 100 mg tablet sig: one (1) tablet po bid (2 times a day). 3. levetiracetam 250 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 4. cetirizine 10 mg tablet sig: one (1) tablet po qd (). 5. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 6. fluticasone-salmeterol 100-50 mcg/dose disk with device sig: one (1) puff inhalation (2 times a day). 7. multivitamin capsule sig: one (1) cap po daily (daily). 8. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 9. lorazepam 0.5 mg tablet sig: 0.5 tablet po q4-6h (every 4 to 6 hours) as needed. 10. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 11. chlorpheniramine-hydrocodone 8-10 mg/5 ml suspension, sust. release 12hr sig: five (5) ml po q12h (every 12 hours) as needed. 12. fluticasone 50 mcg/actuation aerosol, spray sig: two (2) spray nasal qam (once a day (in the morning)). 13. magnesium oxide 140 mg capsule sig: two (2) capsule po hs (at bedtime). 14. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. 15. trazodone 50 mg tablet sig: one (1) tablet po hs (at bedtime) as needed. 16. dexamethasone 4 mg tablet sig: one (1) tablet po q8h (every 8 hours): wean as directed. disp:*90 tablet(s)* refills:*0* discharge disposition: home with service facility: discharge diagnosis: radiation necrosis of brain discharge condition: stable, awake and alert, tolerating pos discharge instructions: please f/u with nsurg in weeks. please continue the decadron as outlined below followup instructions: provider: phone: date/time: 11:00 provider: , m.d. date/time: 11:00 procedure: other operations on extraocular muscles and tendons other excision or destruction of lesion or tissue of brain other repair of cerebral meninges diagnoses: asthma, unspecified type, unspecified personal history of malignant neoplasm of breast other convulsions antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cerebral artery occlusion, unspecified without mention of cerebral infarction polyneuropathy due to drugs 

Answer: The patient is high likely exposed to